Home

Raymond Anthony Low

CIK 1391388 · VP, Finance & Controller · last filed 2017-10-16

Raymond Anthony Low is a VP, Finance & Controller who has filed 18 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for SCLN, was dated Oct 16, 2017. Current disclosed insider exposure totals $3.0M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.00M

Companies

2

Total Filings

18

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SCICLONE PHARMACEUTICALS INC (SCLN) Delisted VP, Finance & Controller 0 — — $0 9 2017-10-16
AXTI Chief Financial Officer 56,000 $53.49 $3.00M $0 9 2012-11-19

Recent Filings

18 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2017-10-16 SCICLONE PHARMACEUTICALS INC (SCLN) Delisted Mixed −26,498 -$422.0K EDGAR
2017-08-16 SCICLONE PHARMACEUTICALS INC (SCLN) Delisted Exer (M) +10,000 $0 EDGAR
2017-06-14 SCICLONE PHARMACEUTICALS INC (SCLN) Delisted Exer (M) +1,250 $0 EDGAR
2017-03-17 SCICLONE PHARMACEUTICALS INC (SCLN) Delisted Exer (M) +1,250 $0 EDGAR
2017-03-09 SCICLONE PHARMACEUTICALS INC (SCLN) Delisted Grant (A) — $0 EDGAR
2016-08-16 SCICLONE PHARMACEUTICALS INC (SCLN) Delisted Mixed +1,250 $0 EDGAR
2016-03-17 SCICLONE PHARMACEUTICALS INC (SCLN) Delisted Grant (A) — $0 EDGAR
2015-03-18 SCICLONE PHARMACEUTICALS INC (SCLN) Delisted Grant (A) — $0 EDGAR
2013-10-16 SCICLONE PHARMACEUTICALS INC (SCLN) Delisted Grant (A) — $0 EDGAR
2012-11-19 AXTI Grant (A) +8,000 $0 EDGAR
Showing 1–10 of 18
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.